Amorphous magnesium-substituted calcium phosphate compositions and their uses
US10596122B2 · kind B2 · utility
0Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2014 |
| Grant date | Mar 24, 2020 |
| Priority date | — |
| Expiry date | Nov 5, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC01B25/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Amorphous magnesium-substituted calcium, phosphate compositions and their medical uses are described, in particular for use in delivering cargo materials, such as cargo molecules or cargo nanoparticles contained in pores of the amorphous magnesium-substituted calcium phosphate to cells of the immune system, for example as therapeutic approaches for the treatment of inflammatory bowel diseases, and in particular Crohn's disease, autoimmune diseases, allergy and for therapeutic vaccination.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.